178 related articles for article (PubMed ID: 22208429)
1. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G
J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429
[TBL] [Abstract][Full Text] [Related]
2. A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats.
Tyler B; Fowers KD; Li KW; Recinos VR; Caplan JM; Hdeib A; Grossman R; Basaldella L; Bekelis K; Pradilla G; Legnani F; Brem H
J Neurosurg; 2010 Aug; 113(2):210-7. PubMed ID: 20001591
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of oncogel delays paresis in rat metastatic spinal tumor model.
Bagley CA; Bookland MJ; Pindrik JA; Ozmen T; Gokaslan ZL; Witham TF
J Neurosurg Spine; 2007 Aug; 7(2):194-8. PubMed ID: 17688059
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis.
Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842
[TBL] [Abstract][Full Text] [Related]
5. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.
Vellimana AK; Recinos VR; Hwang L; Fowers KD; Li KW; Zhang Y; Okonma S; Eberhart CG; Brem H; Tyler BM
J Neurooncol; 2013 Feb; 111(3):229-36. PubMed ID: 23224713
[TBL] [Abstract][Full Text] [Related]
6. Microsurgical removal of intramedullary spinal cord gliomas in a rat spinal cord decreases onset to paresis, an animal model for intramedullary tumor treatment.
Pennant WA; Sciubba DM; Noggle JC; Tyler BM; Tamargo RJ; Jallo GI
Childs Nerv Syst; 2008 Aug; 24(8):901-7. PubMed ID: 18317780
[TBL] [Abstract][Full Text] [Related]
7. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
Vukelja SJ; Anthony SP; Arseneau JC; Berman BS; Cunningham CC; Nemunaitis JJ; Samlowski WE; Fowers KD
Anticancer Drugs; 2007 Mar; 18(3):283-9. PubMed ID: 17264760
[TBL] [Abstract][Full Text] [Related]
9. EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video).
Matthes K; Mino-Kenudson M; Sahani DV; Holalkere N; Fowers KD; Rathi R; Brugge WR
Gastrointest Endosc; 2007 Mar; 65(3):448-53. PubMed ID: 17173909
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
[TBL] [Abstract][Full Text] [Related]
11. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
[TBL] [Abstract][Full Text] [Related]
12. Local non-viral gene delivery of apoptin delays the onset of paresis in an experimental model of intramedullary spinal cord tumor.
Pennant WA; An S; Gwak SJ; Choi S; Banh DT; Nguyen AB; Song HY; Ha Y; Park JS
Spinal Cord; 2014 Jan; 52(1):3-8. PubMed ID: 24190077
[TBL] [Abstract][Full Text] [Related]
13. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
[TBL] [Abstract][Full Text] [Related]
14. OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system.
Elstad NL; Fowers KD
Adv Drug Deliv Rev; 2009 Aug; 61(10):785-94. PubMed ID: 19422870
[TBL] [Abstract][Full Text] [Related]
15. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.
Storm PB; Moriarity JL; Tyler B; Burger PC; Brem H; Weingart J
J Neurooncol; 2002 Feb; 56(3):209-17. PubMed ID: 12061726
[TBL] [Abstract][Full Text] [Related]
16. Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer.
DuVall GA; Tarabar D; Seidel RH; Elstad NL; Fowers KD
Anticancer Drugs; 2009 Feb; 20(2):89-95. PubMed ID: 19209024
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.
Lillehei KO; Kong Q; Withrow SJ; Kleinschmidt-DeMasters B
Neurosurgery; 1996 Dec; 39(6):1191-7; discussion 1197-9. PubMed ID: 8938774
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.
Weingart JD; Thompson RC; Tyler B; Colvin OM; Brem H
Int J Cancer; 1995 Sep; 62(5):605-9. PubMed ID: 7665233
[TBL] [Abstract][Full Text] [Related]
19. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
20. Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.
Legnani FG; Pradilla G; Thai QA; Fiorindi A; Recinos PF; Tyler BM; Gaini SM; DiMeco F; Brem H; Olivi A
J Neurooncol; 2006 May; 77(3):225-32. PubMed ID: 16609837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]